By Moses Godonu

The Director-General, National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Christianah Adeyeye, has announced the approval of the production of Chloroquine for clinical trials as it has been proven potentially to reduce the risk of contracting the deadly virus.

She said Chloroquine is a common malaria vaccine but has been worked upon to fight against the COVID-19, though still undergoing trials.

In another development, the Lagos State Government has urged residents to observed personal hygiene.

 

About Author

Show Buttons
Hide Buttons